drugset / Trial / NCT00663962

Pregabalin and Post-thoracotomy Pain

NCT00663962

Phase 4 Completed 15 enrolled Queen's University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

With Institutional Ethics Board approval and signed informed consent, a pilot investigation was conducted in which 15 adult patients scheduled to undergo a thoractomy were randomly assigned to receive 1) 150 mg pregabalin 1 hour preoperatively and then 7 days postoperatively (BID) or 2) 300 mg pregabalin 1 hour preoperatively and 7 days postoperatively (BID) or 3) placebo for same regimen to assess the feasibility, safety and compliance of this drug regimen on this patient population. This assessment was necessary in order to plan a future fully powered randomized controlled trial looking at the efficacy of perioperative pregabalin ifor reducing the incidence/severity of chronic post-thoracotomy pain.

Timeline

Start
2008-04
Primary completion
2008-11
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg Oral
Subject Pregabalin Small molecule 300 mg Oral

Indications